OSR (NASDAQ:OSRH) Posts Quarterly Earnings Results

OSR (NASDAQ:OSRH) posted its earnings results on Wednesday. The company reported ($0.10) earnings per share for the quarter, Zacks reports. The company had revenue of $0.63 million during the quarter.

OSR Trading Down 8.8%

Shares of OSR stock traded down $0.05 during trading hours on Friday, hitting $0.52. 479,499 shares of the company were exchanged, compared to its average volume of 3,233,814. The business has a 50-day moving average of $0.62 and a 200-day moving average of $0.93. OSR has a 1 year low of $0.45 and a 1 year high of $13.30. The stock has a market capitalization of $11.12 million, a price-to-earnings ratio of -0.51 and a beta of 1.41.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on OSRH shares. Wall Street Zen raised shares of OSR to a “sell” rating in a report on Saturday, October 18th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of OSR in a research report on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

OSR Company Profile

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D “platform technologies” versus “assets only” companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials.